After decades of having to juggle multiple devices and fingerprick systems to take their own blood sugar readings and use them to calculate insulin dosages,
This award is supported by all the main diabetes professional organisations and charities as well as Desang, and is now in its 12th year. It
The American Diabetes Association(ADA), has applauded U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) for recently introducing legislation which aims to make insulin more
All 130,000 Australians with Type 1 diabetes will now get access to subsidised continuous glucose monitoring (CGM) devices under the newly-elected Australian Prime Minister Anthony
The InDependent Diabetes Trust (IDDT) have announced another one-day event at the Kettering Park Hotel on Saturday 29 October 2022. Entitled ‘Changing Times’ to reflect
Although things do tend to be a little quieter over the summer months, the fact is that this is another issue filled-to-busting with news and
Vertex to acquire ViaCyte, with the goal of accelerating its potentially curative VX-880 programmes in Type 1 diabetes. ViaCyte brings tools, technologies and assets with
An international team of scientists led by Anglia Ruskin University (ARU) has announced “extremely positive results” from laboratory trials of a compound that could one
The latest issue of Type 1 Discovery magazine, which aims to give the latest news, events, features and research updates about Type 1 diabetes and
ViCentra is closing its UK operations for the time being due to current supply issues. Two years ago ViCentra withdrew the product from the UK
